News After The Bell SRNE..9.20..Sorrento Therapeutics Sorrento Received Authorization From UK Regulatory Agency To Conduct Phase2 Clinical Trial For Covi-Drops In An Outpatient Setting
High Recommendation From Avise Analytics ENZC..2770..Enzolytics A Buy and Hold Diamond In The Rough Why Enzolytics Is a Compelling Choice Company developes antiviral peptides and monoclonal antibodies for treatment of Infectious Diseases Uses a combination of patented-HIV therapeutics and an exclusive methodology for creating fully human IgGi monoclonal antibodies which can target and neutralize HIV Virus to treat infectious diseases with non-toxic passive immunotherapy Company's lead drug candidate ITV-1 which is a suspension of inactivated Pepsin fragment that has demonstrated the potential to strengthen the immune system and neutralize the HIV Virus Enzolytics portfolio of therapeutics may not only be used as immunotherapeutic treatment for HIV/AIDS but also serve as a prophylactic and therapeutic vaccine against HIV The Company announced protocol to produce threapeutics for HIV as well as existing and future Pandemics Company has built multiple strategic research and development collaborations and partnerships Nice steady daily volume Did reach a High of .92 on Feb..10
Not Your Typical MEME Stock SENS..4.01..Senseonics Reditt Chatter Drove Price up Friday May 11th trading at 1.62 with 17 million volume June 11 reached high of 4.20 with 168 million volume Senseonics concentrates on glucose monitoring systems for diabetics This isn't your typical Reddit stock because of strong fundamentals so you can ride the wave up without eventually falling off a cliff Market Cap 1.7 Billion Big Holder Vanguard with $30 million worth Revenue has grown faster 220% than US Industry average of 17% Return on Equity 360% At 2.50 considered significantly undervalued Before Reddit A Barchart Strong Buy
Did It ,Come For a Reddit Visit Friday Or Is It A New Family Member RCON..6.24 Provides hardware, software and onsite services to companies in petroleum and mining industry in China Low yesterday 4.62..High 17.50 Average Daily Volume 500K..Friday volume 122 Million Does have a Low Float of 3.62 Million
Buy and Hold Cannabis play TCNNF..37.67..Trulieve Cannabis Revenue Doubled Year Over Year Q1 193.8 Million Q1 Adjusted EBITDA was 90.8 Million Most of the growth stemmed from organic expnsion in company's home state of florida..Revenue jumped 15% from previous quarter Trulieve's advantage over competition is Florida's market..Also getting started in Penn..Cal..Conn..and West V.. Expects to close purchase of harvest Health and Recreation later this year,,Deal will open up markets in five additional states and boost addressable market by 50% Stock trade at a price-to-sale multiple of 7.6 Market Cap 6 Billion Float 61 Million TipRanks Strong Buy with Target price 70.23
From Bear To Bull GBS..4.31..GBS Bio-Tech that creates biosensor diagnostic technology..Main product Saliva Glucose Biosensor used for diabetes management. It has an active research agreement with Johns Hopkins Bloomberg School Of Public Health to develope saliva-based diagnostic tests.. On June 8 GBS announced 90% of patients questioned are in favor of a saliva-based glucose test as an alternative to finger-prick tests. VERY LOW FLOAT 9.8 Million
Two With Upside AYRW.F and CRLBF Ayr and Cresco Multi-state cannabis operators. Ayr operates in six states Cresco operates in ten states Ayr reported 74% year over year Revenue growth in First quarter Cresco 169% year over year growth Cresco Market Cap 2.8 Billion Ayr float 46 Million Shares of both Ayr and Cresco currently trade a price-to-sales multiples that are well above peers Ayr recently closed on purchase of Liberty health Sciences a deal that makes Company fourth biggest in florida Cresco competing in Florida thanks to acquisition of bluma Wellness Like all Cannabis Stocks both will benefit by Cannabis Reform at Federal Level and by more states passing legislation allowing for Recreational use Ayr..28.74 TipRanks Strong buy with Target price 42.40 Cresco ...11.47 TipRanks Strong Buy with Target Price 21.63
MEIP..3.29..Mei Pharma Results this week..Clinical Data from a Phase 1b Study of Zandelisib in clinical development for the treatment of B-cell malignancies and the trial design of Coastal ..a Phase 3 Study of Zandelisib combined with Rituximab Revenue Forecast To Grow 26% per year TipRanks Strong Buy with Target price 8.67
Stock Wall Street Expects To double Or Triple Over coming Year SRNE..8.97..Sorrento Therapeutic Implied Upside 216% With a Price Target of 27.50 the consensus is Sorrento's shares will more than triple over coming year Company has 11 Covid-19 Programs in various clinical or regulatory stages Filed for emergency use authorization EUA..for Covi-Track antibody test June 2020..as well as its Covi-Stix rapid covid-19 test in December These tests could represent 1 Billion in annual sales opportunities Has extensive pipeline beyond its diagnostics Four clinical-stage Covid-19 treatments Six clinical-stage cancer immunotherapies Two clinical-stage pain trials Two clinical-stage trials delivering injectable medicine into lymphatic and systemic capillaries
Buy and Hold Both have Upside because of the Computer chip shortage worldwide AVT..43.92..Avnet ARW..120.89..Arrow Electronics Both providers of products services and solutions to industrial and commercial users of electronic components and computing solutions
News at 9 GTEH....0028 Gentech To Acquire High Growth Sports Nutrition Brand NXTBAR..As Sinfit Nutrition Roll-up strategy continues..
News This Morning ENZC...29.. Enzolytics Announced Its Progress toward Completion Of Clinical Trials For ITS Anti-HIV ITV-1 Therapeutic And Plans for Its Distribution Throughout Europe
SRNE...Up 10%..9.80 Sorrento Announced this Morning Collaboration with Mayo Clinic Inked Research Pact For Ipilimunab-Delivering Sofusa In Melonoma Patients
Last Wednesday Listed GTEH and how wasn't much now but in a couple of years could make you mucho dollars Alerted at .0023 Today Up 25% to now .0034 Might not hold gains but on its way to slow growth Don't look back in a couple of years and wonder ..What If..
A Swing Or Buy and Hold and forgetta about it .. GGII..Down 12%...0198 April 23 Low .009 May 11 Reached High .1679 Last week announced they're launching a new portfolio of flavored hemp paper wraps also called hemp blunts..for sale in convenience stores supermarkets and smoke shops to roll hemp tobacco smoking herbs and cannabis..launching the new portfolio with a 230K purchase order Barchart Buy Walletinvestor one year Target Price .04..Five year ..12
News at Noon GGII...021 Hempacco the leading manufacturer of herb and hemp cigarettes in the USA announced their joint venture agreement and 50% ownership stake in Calivebes Delat8 LLC. to develop and sell Delta 8 smokables directly to comsumers through their ecommerce online portal CalivibesDelta8.com
